LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

11.98 4.81

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.24

Max

12.1

Chiffres clés

By Trading Economics

Revenu

479M

-5.4M

Ventes

-14M

402M

Marge bénéficiaire

-1.344

Employés

4,396

EBITDA

526M

54M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+14.84% upside

Dividendes

By Dow Jones

Prochains Résultats

26 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-374M

882M

Ouverture précédente

7.17

Clôture précédente

11.98

Sentiment de l'Actualité

By Acuity

50%

50%

165 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 févr. 2026, 22:31 UTC

Résultats

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 févr. 2026, 22:18 UTC

Résultats

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 févr. 2026, 22:11 UTC

Résultats

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 févr. 2026, 21:52 UTC

Résultats

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 févr. 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 févr. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 févr. 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 févr. 2026, 23:34 UTC

Market Talk
Résultats

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 févr. 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 févr. 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 févr. 2026, 22:45 UTC

Résultats

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 févr. 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 févr. 2026, 22:37 UTC

Résultats

Nutrien 4Q EPS $1.18 >NTR.T

18 févr. 2026, 22:37 UTC

Résultats

Nutrien 4Q Sales $5.34B >NTR.T

18 févr. 2026, 22:35 UTC

Résultats

Pan American Silver 4Q EPS $1.07 >PAAS

18 févr. 2026, 22:35 UTC

Résultats

Pan American Silver 4Q Rev $1.18B >PAAS

18 févr. 2026, 22:30 UTC

Résultats

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 févr. 2026, 22:29 UTC

Résultats

Kinross Gold 4Q EPS 75c >K.T

18 févr. 2026, 22:22 UTC

Résultats

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 févr. 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 févr. 2026, 22:16 UTC

Résultats

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 févr. 2026, 22:05 UTC

Résultats

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 févr. 2026, 22:03 UTC

Résultats

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q Sales $929M >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 févr. 2026, 22:00 UTC

Résultats

Kinross Gold 4Q Adj EPS 67c >KGC

18 févr. 2026, 22:00 UTC

Résultats

Kinross Gold 4Q Sales $2.02B >KGC

18 févr. 2026, 21:56 UTC

Résultats

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 févr. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

14.84% hausse

Prévisions sur 12 Mois

Moyen 13 USD  14.84%

Haut 13 USD

Bas 13 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

165 / 351Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat